The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Galkin S.A.

Mental Health Research Institute of the Tomsk National Research Medical Center of the Russian Academy of Science

Ivanova S.A.

Tomsk National Research Medical Center of the Russian Academy of Sciences

Bokhan N.A.

Mental Health Research Institute of the Tomsk National Research Medical Center of the Russian Academy of Science

Current methods for predicting therapeutic response in patients with depressive disorders

Authors:

Galkin S.A., Ivanova S.A., Bokhan N.A.

More about the authors

Read: 1566 times


To cite this article:

Galkin SA, Ivanova SA, Bokhan NA. Current methods for predicting therapeutic response in patients with depressive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(2):15‑21. (In Russ.)
https://doi.org/10.17116/jnevro202212202115

Recommended articles:
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132
The central vein sign in the differential diagnosis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):58-65

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.